Obagi operates in Healthcare, Cosmetics, Dermatology, functioning as Manufacturer and Distributor and Retailer, based in United States, founded in 1988.
Obagi is active in Healthcare, Cosmetics, Dermatology, with 3 identified product associations including Clenziderm Pore Therapy, Obagi C-Therapy Night Cream, and 3 ingredient links such as Edetate Disodium, Fragrance, operating from United States.
Obagi is linked to 3 ingredients: Edetate Disodium, Fragrance, Saponins. INCI names include EDTA. CAS references: 60-00-4, 8047-15-2.
Obagi has 3 product records: Clenziderm Pore Therapy, Obagi C-Therapy Night Cream, Obagi C-Therapy Clarifying Serum, under brands: Sciences de la Peau CRESCITA Inc. /CRESCITA skin sciences Inc, Obagi Medical Products, a division of Valeant Pharmaceuticals North America LLC., within the Healthcare ecosystem.
Obagi has 71 people records, including Avp Of Finance, Director, Digital Operations & Strategy, across Vp, Director levels.
This profile combines organization, product, ingredient, and narrative signals into a higher-fidelity company record.
CAS: 60-00-4 · INCI: EDTA
CAS: 8047-15-2
Brand: Sciences de la Peau CRESCITA Inc. /CRESCITA skin sciences Inc · Industry: Healthcare
Brand: Obagi Medical Products, a division of Valeant Pharmaceuticals North America LLC. · Industry: Healthcare
Brand: Obagi Medical Products, a division of Valeant Pharmaceuticals North America LLC. · Industry: Healthcare
Obagi has 71 people records, including Avp Of Finance, Director, Digital Operations & Strategy, across Vp, Director levels.
Obagi is related to companies such as ARFAMEX Dermatology, Optaderm Pharma Incorporated, DermaMedica d.o.o., identified through shared industry signals, ingredient overlap, and product ecosystem alignment.
Data-backed questions about Obagi in Healthcare, Cosmetics, Dermatology, United States.
© Copyright 2026 Dietary Business Intelligence LLC. All Rights Reserved.
